Regulation of prostaglandin synthesis by antiinflammatory drugs

Journal of Rheumatology

Volumn 24, Issue SUPPL. 47, 1997, Pages 32-39

  Robinson, Dwight R ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Department of Medicine ^*  (United States)

Author keywords

Arthritis; Eicosanoids; Leukotrienes; Prostaglandin endoperoxide synthase; Prostaglandins; Rheumatoid; Thromboxanes

Indexed keywords

ANTIINFLAMMATORY AGENT; DICLOFENAC; ETODOLAC; FLURBIPROFEN; INDOMETACIN; KETOROLAC; LEUKOTRIENE; MECLOFENAMIC ACID; NABUMETONE; NAPROXEN; PHENYLBUTAZONE; PIROXICAM; PROSTAGLANDIN SYNTHASE; SULINDAC; THROMBOXANE; PROSTAGLANDIN;

ANIMAL EXPERIMENT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; RHEUMATOID ARTHRITIS; ANIMAL; BIOSYNTHESIS; CHEMISTRY; IMMUNOLOGY; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS; HUMANS; PROSTAGLANDINS;

EID: 0031043939     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Robinson DR: Lipid mediators of inflammation. Rheum Dis Clin North Am 1987;13:385-405.
2. Smith WL, Marnett LJ: Prostaglandin endoperoxide synthase: Structure and catalysis. Biochim Biophys Acta 1991;1083:1-17.
3. Smith WL, Meade EA, DeWitt DL: Interactions of PGH synthase isozymes-1 and -2 with NSAIDs. Ann NY Acad Sci 1994;744:50-7.
4. 2 synthase-1. Nature 1994;367:243-9.
5. Robinson DR: Eicosanoids and related agents. In: McCarty DJ, Koopman WJ, eds. Arthritis and Allied Conditions. A Textbook of Rheumatology, 13th ed. Philadelphia: Lea & Febiger, 1996:in press.
6. Laneuville O, Breuer DK, DeWitt DL, Hla T, Funk CD, Smith WL: Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 1994;271:927-34.
7. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR: Selectivity of nonsteroidal antiinflamniatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1994;90:11693-7.
8. Vane JR, Botting RM: New insights into the mode of action of anti-inflammatory drugs. Inflainm Res 1995;44:1-10.
9. Dinchuk JE, Car BD, Focht RJ, et al: Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 1995;318:406-9.
10. Langenbach R, Morham SG, Tiano HF, et al: Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 1995;83:483-92.
11. Morham SG, Langenbach R, Loftin CD, et al: Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1995;83:473-82.
12. DeWitt D, Smith WL: Yes, but do they still get headaches? Cell 1995;83:345-8.
13. Tsujii M, DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995;83:493-501.
14. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC: Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994;121:241-6.
15. Reddy BS, Rao CV, Rivenson A, Kelloff G: Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis 1993;14:1493-7.
16. Giardiello FM, Hamilton SR, Krush AJ, et al: Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313-6.
17. Pasricha PJ, Bedi A, O'Connor K, et al: The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology 1995;109:994-8.
18. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN: Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994;107:1183-8.
19. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S: Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 1995;55:2556-9.
20. Lewis RA, Austen KF, Soberman RJ: Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990;323:645-55.
21. Henderson WR Jr: The role of leukotrienes in inflammation. Ann Intern Med 1994;121:684-97.
22. 4 synthase and 5-lipoxygenase activating protein. Regulators of the biosynthesis of sulfido-leukotrienes. Ann NY Acad Sci 1994;744:78-83.
23. Weinblatt ME, Kremer JM, Coblyn JS, et al: Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis. J Rheumatol 1992;19:1537-41.
24. 4 plays a critical role in the progression of collagen-induced arthritis. Proc Natl Acad Sci USA 1995;92:517-21.
25. Degreef H, Dockx P, De Doncker P, De Beule K, Cauwenbergh G: A double-blind vehicle-controlled study of R 68 151 in psoriasis: A topical 5-lipoxygenase inhibitor. J Am Acad Dermatol 1990;22:751-5.
26. de Jong EMGJ, van Vlijmen IMMJ, Scholte JCM, et al: Clinical and biochemical effects of an oral leukotriene biosynthesis inhibitor (MK886) in psoriasis. Skin Pharmacol 1991;4:278-85.
27. Goulet JL, Snouwaert JN, Latour AM, Coffman TM, Koeller BH: Altered inflammatory responses in leukotriene-deficient mice. Proc Natl Acad Sci USA 1994;91:12852-6.
28. Abramson SB, Weissmann G: The mechanisms of action of nonsteroidal antiinflammatory drugs. Arthritis Rheum 1989;32:1-9.
29. Wu KK, Sanduja R, Tsai A-L, Ferhanoglu B, Loose-Mitchell DS: Aspirin inhibits interleukin 1-induced prostaglandin H synthase expression in cultured endothelial cells. Proc Natl Acad Sci USA 1991;88:2384-7.
30. Silverstein FE, Graham DY, Senior JR, et al: Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995;123:241-9.
31. Raskin JB, White RH, Jackson JE, et al: Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: A comparison of three regimens. Ann Intern Med 1995;123:344-50.
32. Clive DM, Stoff JS: Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1984;310:563-72.
33. Lee M, Cryer B, Feldman M: Dose effects of aspirin on gastric prostaglandins and stomach mucosal injury. Ann Intern Med 1994;120:184-9.